Uterine adenomyosis: an update for GPs
- PMID: 37884370
- PMCID: PMC10617966
- DOI: 10.3399/bjgp23X735549
Uterine adenomyosis: an update for GPs
Conflict of interest statement
Katy Vincent has received research funding from Bayer HealthCare (BH) and honoraria for talks and consultancy fees from BH, AbbVie, and Eli Lilly. Thomas Round is
References
-
- Dason ES, Maxim M, Sanders A, et al. Guideline No. 437: diagnosis and management of adenomyosis. J Obstet Gynaecol Can. 2023;45(6):417–429.e1. - PubMed
-
- Hammer A, Rositch AF, Kahlert J, et al. Global epidemiology of hysterectomy: possible impact on gynecological cancer rates. Am J Obstet Gynecol. 2015;213(1):23–29. - PubMed
-
- Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):547–555. - PubMed
-
- Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical